TGFI1_HUMAN - dbPTM
TGFI1_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID TGFI1_HUMAN
UniProt AC O43294
Protein Name Transforming growth factor beta-1-induced transcript 1 protein
Gene Name TGFB1I1
Organism Homo sapiens (Human).
Sequence Length 461
Subcellular Localization Cell junction, focal adhesion. Nucleus matrix. Cytoplasm, cytoskeleton. Associated with the actin cytoskeleton
colocalizes with stress fibers.
Protein Description Functions as a molecular adapter coordinating multiple protein-protein interactions at the focal adhesion complex and in the nucleus. Links various intracellular signaling modules to plasma membrane receptors and regulates the Wnt and TGFB signaling pathways. May also regulate SLC6A3 and SLC6A4 targeting to the plasma membrane hence regulating their activity. In the nucleus, functions as a nuclear receptor coactivator regulating glucocorticoid, androgen, mineralocorticoid and progesterone receptor transcriptional activity. May play a role in the processes of cell growth, proliferation, migration, differentiation and senescence. May have a zinc-dependent DNA-binding activity..
Protein Sequence MEDLDALLSDLETTTSHMPRSGAPKERPAEPLTPPPSYGHQPQTGSGESSGASGDKDHLYSTVCKPRSPKPAAPAAPPFSSSSGVLGTGLCELDRLLQELNATQFNITDEIMSQFPSSKVASGEQKEDQSEDKKRPSLPSSPSPGLPKASATSATLELDRLMASLSDFRVQNHLPASGPTQPPVVSSTNEGSPSPPEPTGKGSLDTMLGLLQSDLSRRGVPTQAKGLCGSCNKPIAGQVVTALGRAWHPEHFVCGGCSTALGGSSFFEKDGAPFCPECYFERFSPRCGFCNQPIRHKMVTALGTHWHPEHFCCVSCGEPFGDEGFHEREGRPYCRRDFLQLFAPRCQGCQGPILDNYISALSALWHPDCFVCRECFAPFSGGSFFEHEGRPLCENHFHARRGSLCATCGLPVTGRCVSALGRRFHPDHFTCTFCLRPLTKGSFQERAGKPYCQPCFLKLFG
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
1Acetylation-------MEDLDALL
-------CHHHHHHH
9.0222814378
9PhosphorylationEDLDALLSDLETTTS
HHHHHHHHHHHHHHC
40.7922199227
13PhosphorylationALLSDLETTTSHMPR
HHHHHHHHHHCCCCC
42.5427732954
14PhosphorylationLLSDLETTTSHMPRS
HHHHHHHHHCCCCCC
19.5427732954
15PhosphorylationLSDLETTTSHMPRSG
HHHHHHHHCCCCCCC
24.8527732954
16 (in isoform 2)Phosphorylation-18.72-
16PhosphorylationSDLETTTSHMPRSGA
HHHHHHHCCCCCCCC
18.7227732954
21PhosphorylationTTSHMPRSGAPKERP
HHCCCCCCCCCCCCC
33.1729759185
27 (in isoform 2)Phosphorylation-41.68-
32 (in isoform 2)Phosphorylation-9.39-
33PhosphorylationERPAEPLTPPPSYGH
CCCCCCCCCCCCCCC
44.4528355574
36 (in isoform 2)Phosphorylation-41.19-
37PhosphorylationEPLTPPPSYGHQPQT
CCCCCCCCCCCCCCC
49.9021955146
38PhosphorylationPLTPPPSYGHQPQTG
CCCCCCCCCCCCCCC
25.1321955146
44PhosphorylationSYGHQPQTGSGESSG
CCCCCCCCCCCCCCC
39.7421955146
46PhosphorylationGHQPQTGSGESSGAS
CCCCCCCCCCCCCCC
42.6522199227
49PhosphorylationPQTGSGESSGASGDK
CCCCCCCCCCCCCCC
37.2821955146
50PhosphorylationQTGSGESSGASGDKD
CCCCCCCCCCCCCCC
33.7922199227
51 (in isoform 2)Phosphorylation-32.80-
53PhosphorylationSGESSGASGDKDHLY
CCCCCCCCCCCCCEE
51.5625850435
60PhosphorylationSGDKDHLYSTVCKPR
CCCCCCEEEEECCCC
10.0121945579
61PhosphorylationGDKDHLYSTVCKPRS
CCCCCEEEEECCCCC
22.2621945579
62PhosphorylationDKDHLYSTVCKPRSP
CCCCEEEEECCCCCC
19.1621945579
65 (in isoform 2)Phosphorylation-38.85-
68PhosphorylationSTVCKPRSPKPAAPA
EEECCCCCCCCCCCC
45.8929255136
80PhosphorylationAPAAPPFSSSSGVLG
CCCCCCCCCCCCCCC
34.7823663014
81O-linked_GlycosylationPAAPPFSSSSGVLGT
CCCCCCCCCCCCCCC
28.9831492838
81PhosphorylationPAAPPFSSSSGVLGT
CCCCCCCCCCCCCCC
28.9826657352
82PhosphorylationAAPPFSSSSGVLGTG
CCCCCCCCCCCCCCH
29.8830266825
83PhosphorylationAPPFSSSSGVLGTGL
CCCCCCCCCCCCCHH
34.5623663014
88PhosphorylationSSSGVLGTGLCELDR
CCCCCCCCHHHHHHH
23.8724117733
102 (in isoform 2)Ubiquitination-18.53-
105 (in isoform 2)Phosphorylation-6.57-
109 (in isoform 2)Ubiquitination-39.36-
120 (in isoform 2)Phosphorylation-5.75-
122PhosphorylationFPSSKVASGEQKEDQ
CCCCCCCCCCCCCCC
45.9426657352
123 (in isoform 2)Phosphorylation-31.45-
124 (in isoform 2)Phosphorylation-56.86-
126 (in isoform 2)Phosphorylation-59.98-
130PhosphorylationGEQKEDQSEDKKRPS
CCCCCCCCCCCCCCC
61.1526657352
137PhosphorylationSEDKKRPSLPSSPSP
CCCCCCCCCCCCCCC
57.8729255136
140PhosphorylationKKRPSLPSSPSPGLP
CCCCCCCCCCCCCCC
61.2429255136
141PhosphorylationKRPSLPSSPSPGLPK
CCCCCCCCCCCCCCC
27.7029255136
143PhosphorylationPSLPSSPSPGLPKAS
CCCCCCCCCCCCCCC
33.2825463755
150PhosphorylationSPGLPKASATSATLE
CCCCCCCCCCCHHHH
37.9020873877
152PhosphorylationGLPKASATSATLELD
CCCCCCCCCHHHHHH
19.1926657352
153PhosphorylationLPKASATSATLELDR
CCCCCCCCHHHHHHH
20.9726657352
155PhosphorylationKASATSATLELDRLM
CCCCCCHHHHHHHHH
22.1130242111
164PhosphorylationELDRLMASLSDFRVQ
HHHHHHHHHHHCCHH
17.9123911959
166PhosphorylationDRLMASLSDFRVQNH
HHHHHHHHHCCHHHC
32.0123403867
169 (in isoform 2)Phosphorylation-33.82-
170 (in isoform 2)Phosphorylation-7.25-
175 (in isoform 2)Phosphorylation-19.48-
177PhosphorylationVQNHLPASGPTQPPV
HHHCCCCCCCCCCCC
43.2818691976
177 (in isoform 2)Phosphorylation-43.28-
180PhosphorylationHLPASGPTQPPVVSS
CCCCCCCCCCCCCCC
58.1828060719
186PhosphorylationPTQPPVVSSTNEGSP
CCCCCCCCCCCCCCC
31.5122167270
187PhosphorylationTQPPVVSSTNEGSPS
CCCCCCCCCCCCCCC
24.5222167270
188PhosphorylationQPPVVSSTNEGSPSP
CCCCCCCCCCCCCCC
29.7722167270
192PhosphorylationVSSTNEGSPSPPEPT
CCCCCCCCCCCCCCC
18.9429255136
194PhosphorylationSTNEGSPSPPEPTGK
CCCCCCCCCCCCCCC
55.5823401153
199PhosphorylationSPSPPEPTGKGSLDT
CCCCCCCCCCCCHHH
50.2729255136
203PhosphorylationPEPTGKGSLDTMLGL
CCCCCCCCHHHHHHH
26.9326657352
207SulfoxidationGKGSLDTMLGLLQSD
CCCCHHHHHHHHHHH
2.5230846556
213PhosphorylationTMLGLLQSDLSRRGV
HHHHHHHHHHHHCCC
40.2528857561
216PhosphorylationGLLQSDLSRRGVPTQ
HHHHHHHHHCCCCCC
25.5626657352
284PhosphorylationECYFERFSPRCGFCN
HHHHHCCCCCCCCCC
20.0428555341
380PhosphorylationRECFAPFSGGSFFEH
CHHCCCCCCCCCCCC
40.9826657352
383PhosphorylationFAPFSGGSFFEHEGR
CCCCCCCCCCCCCCC
30.2227251275
386 (in isoform 2)Phosphorylation-38.73-
403PhosphorylationHFHARRGSLCATCGL
CCHHCCCCCCHHCCC
20.6126846344
407PhosphorylationRRGSLCATCGLPVTG
CCCCCCHHCCCCCCC
13.2023927012
413PhosphorylationATCGLPVTGRCVSAL
HHCCCCCCCCHHHHH
19.5723927012
418PhosphorylationPVTGRCVSALGRRFH
CCCCCHHHHHCCCCC
22.7724670416
430PhosphorylationRFHPDHFTCTFCLRP
CCCCCCEEEEEECCC
13.7624719451
449UbiquitinationSFQERAGKPYCQPCF
CHHHHCCCCCCCCHH
31.65-
458UbiquitinationYCQPCFLKLFG----
CCCCHHHHHCC----
22.86-

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
60YPhosphorylationKinasePYK2Q14289
PSP
60YPhosphorylationKinasePTK2BP70600
GPS
60YPhosphorylationKinaseFYNP06241
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of TGFI1_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of TGFI1_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
GCR_HUMANNR3C1physical
10848625
FAK2_HUMANPTK2Bphysical
9422762
FAK2_HUMANPTK2Bphysical
11856738
FAK1_HUMANPTK2physical
11463817
PAXI_HUMANPXNphysical
11463817
FAK1_HUMANPTK2physical
9858471
FAK2_HUMANPTK2Bphysical
9858471
VINC_HUMANVCLphysical
9858471
GIT1_RATGit1physical
12153727
HSPB1_HUMANHSPB1physical
11546764
SMAD3_HUMANSMAD3physical
15561701
CBLC_HUMANCBLCphysical
24831009
HSPB1_HUMANHSPB1physical
24831009
HSPB2_HUMANHSPB2physical
24831009
SMAD3_HUMANSMAD3physical
14755691

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of TGFI1_HUMAN

loading...

Related Literatures of Post-Translational Modification
Phosphorylation
ReferencePubMed
"Large-scale proteomics analysis of the human kinome.";
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,Mann M., Daub H.;
Mol. Cell. Proteomics 8:1751-1764(2009).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68 AND SER-186, AND MASSSPECTROMETRY.
"Kinase-selective enrichment enables quantitative phosphoproteomics ofthe kinome across the cell cycle.";
Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,Greff Z., Keri G., Stemmann O., Mann M.;
Mol. Cell 31:438-448(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-192 AND SER-194,AND MASS SPECTROMETRY.
"Global proteomic profiling of phosphopeptides using electron transferdissociation tandem mass spectrometry.";
Molina H., Horn D.M., Tang N., Mathivanan S., Pandey A.;
Proc. Natl. Acad. Sci. U.S.A. 104:2199-2204(2007).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND MASSSPECTROMETRY.
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks.";
Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.;
Cell 127:635-648(2006).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-68, AND MASSSPECTROMETRY.
"Suppression of androgen receptor transactivation by Pyk2 viainteraction and phosphorylation of the ARA55 coregulator.";
Wang X., Yang Y., Guo X., Sampson E.R., Hsu C.-L., Tsai M.-Y., Yeh S.,Wu G., Guo Y., Chang C.;
J. Biol. Chem. 277:15426-15431(2002).
Cited for: FUNCTION, INTERACTION WITH PTK2B/PYK2, AND PHOSPHORYLATION AT TYR-60BY FAK2.
"Phosphorylation of Hic-5 at tyrosine 60 by CAKbeta and Fyn.";
Ishino M., Aoto H., Sasaski H., Suzuki R., Sasaki T.;
FEBS Lett. 474:179-183(2000).
Cited for: MUTAGENESIS OF TYR-60, PHOSPHORYLATION AT TYR-60, AND INTERACTION WITHCSK AND PTK2B/PYK2.

TOP